Health Care SPDR ETF (XLV) Options Indicate A Possible Major Pullback

pills-drugs-biotech1
The options market is sending a bearish signal about the Health Care SPDR ETF (NYSE:XLV) right now, and the suddenly high-flying fund might be due for a major short-term pullback.
NYSE:XLV June 29, 2017 12:27pm

Health Care Investors Should Brace For Impact (XLV)

Medical Device
From Invesco: Commanding much attention last week was the release of the Senate’s version of the American Health Care Act, which was recently passed by the House.
NYSE:XLV June 27, 2017 6:10am

Health Care (XLV) Finally Breaks Out To The Bullish Side

healthcare
From Dana Lyons: As other sectors stumble, health care stocks are finally hitting new all-time highs again after two long years.
NYSE:XLV June 21, 2017 6:23am

Building A Truly Diversified Portfolio Is Much Easier Said Than Done

pie-chart
From Steven Vannelli, CFA: There are three basic ways to manage the risk of an equity portfolio, which you'll find below.
NYSE:XLV June 9, 2017 10:55am

Health Care ETFs In Focus As House Votes To Repeal Obamacare

healthcare
From Brad Hoppmann: Republicans in the House of Representatives finally cobbled together enough "yes" votes to do what they’ve been promising to do for some seven years … repeal and replace the "Affordable Care Act" (ACA), aka Obamacare.
NYSE:XLV May 5, 2017 7:14am

Healthcare ETFs Find Renewed Bull Market Amid Trump Tax Reform Promises

pills healthcare
We've profiled the Healthcare space in terms of relevant ETFs in the sector on several occasions since Trump’s election last year, because it quite simply has been much more volatile than its historical norms.
NYSE:XLV March 15, 2017 12:30pm

These Indexes Are The Best Indicators For A Potential Bear Market Developing

bear-1397235-640x480
From Taki Tsaklanos: Global stock markets remain strong. The leading U.S. stock market indexes keep on moving near all-time highs. European stock market indexes refuse to go lower, and emerging stock markets touched multi-year highs very recently.
NYSE:XLV March 13, 2017 6:08am

Healthcare ETFs Weaken Ahead Of Trump’s Obamacare Replacement Plan

biotech-medical-pills
From Zacks: Healthcare was the top-performing sector of February and is in the spotlight given President Donald Trump’s healthcare overhaul efforts. Trump promised to reduce federal regulations by 75–80% and streamline the Food & Drug Administration (FDA) approval process.
NYSE:XLV March 7, 2017 12:11pm

Healthcare Sector On The Verge Of A Major Breakout — Or Breakdown

pills healthcare
From Taki Tsaklanos: The healthcare stock market sector is the outperforming sector in the S&P 500 in February 2017. Though this is an interesting insight for investors, the more important observation is the chart setup of the health sector (which is discussed in more detail in this article).
NYSE:XLV February 26, 2017 6:41am

A Major Recovery Is Brewing In The Biotech & Healthcare Space

white-pills
From Taki Tsaklanos: Biotechnology was once the darling of stock market investors. Not so anymore, since the summer of 2015 the sector collapsed from 400 points to 250 points in the IBB ETF.
NASDAQ:IBB February 17, 2017 6:33am

The Healthcare Sector’s Performance Has Zero Correlation With Earnings Estimates

Medical Device
From Eric Bush: Equity returns and earnings estimates should presumably be related. It makes intuitive sense that if earnings estimates are increasing for a sector than equity prices for that sector should trend upwards as well.
NYSE:XLV February 15, 2017 6:39am

Health Care ETFs Are Soaring Amid Big Inflows, Muted Trump Worries

biotech-white-pills
Even though rhetoric out of Trump’s White House lately has sounded bearish for prescription pill prices, we have seen bullish momentum in the largest Health Care sector fund in the U.S. listed landscape, XLV (SPDR Health Care Select Sector, Expense Ratio 0.15%), as well as substantial inflows this week.
NYSE:XLV February 9, 2017 12:51pm

Health Care Is An Underappreciated Dividend Sector Right Now

biotech-white-pills
From Marshall Hargrave: For investors looking to invest in health care but who want to play it safe, the best bet is companies that offer superior and transformative drugs.
NYSE:XLV January 25, 2017 10:30am

Healthcare And Biotech ETFs Continue Recovery As Money Pours In

biotech-white-pills
Conventional wisdom had Hillary Clinton as “bad” for the Healthcare space, specifically the Biotechs, given her bold statements on the campaign trail in regards to reining in prescription drug costs across the segment if she were to take office.
NYSE:XLV January 11, 2017 12:10pm

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular


From Our Partners


Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories